FOLLOW-UP IN-DEPTH INTERVIEW GUIDELINES

Similar documents
Assessment Field Activity Collaborative Assessment, Planning, and Support: Safety and Risk in Teams

For our protection, we require verification that you have received this notice. Therefore, please sign below.

Post Distribution Monitoring Report

ANXIETY SYMPTOMS INTERVENTION SESSION HANDOUTS. Introduction to Fighting Fear by Facing Fear. Making a Fears and Worries List

PILI Ohana Facilitator s Guide

Dental Benefits. Under the TeamstersCare Plan, you and your eligible dependents have three basic options when you need dental care.

University College Hospital. Pump school Starting on an insulin pump. Children and Young People s Diabetes Service

For our protection, we require verification that you have received this notice. Therefore, please sign below.

The Mental Capacity Act 2005; a short guide for the carers and relatives of those who may need support. Ian Burgess MCA Lead 13 February 2017

Instructions regarding referral of patients to the Persistent Pain Service

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline)

Pain relief after surgery

DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS

ALCAT FREQUENTLY ASKED QUESTIONS

SESSION HANDOUTS ANXIETY SYMPTOMS INTERVENTION. Assertiveness Checklist and Stepladders Fighting Fear by Facing Fear Form SESSION

A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol.

Patrick J McGahan, MD Orthopaedic Surgeon Specializing in Sports Medicine/Shoulder Reconstruction Surgery Instructions Hip

CONSENT FORM - TESTOSTERONE FOR TRANSGENDER CLIENTS

Imaging tests allow the cancer care team to check for cancer and other problems inside the body.

Patrick J McGahan, MD Orthopaedic Surgeon Specializing in Sports Medicine/Shoulder Reconstruction

Finding the right 90 people in 90 days and what to do with them:

Frequently asked questions: Influenza A (H1N1)v

Module 6: Goal Setting

PILI Lifestyle Program Facilitator s Guide

Swindon Joint Strategic Needs Assessment Bulletin

Success Criteria: Extend your thinking:

Session78-P.doc College Adjustment And Sense Of Belonging Of First-Year Students: A Comparison Of Learning Community And Traditional Students

ACRIN 6666 Screening Breast US Follow-up Assessment Form

Before Your Visit: Mohs Skin Cancer Surgery

Self-Awareness Exercise:

Smoking Cessation Improvement in SFHN Primary Care,

Vaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE

9.2.2 Lesson 8. Introduction. Standards D R A F T

Career Confidence. by Kevin Gaw

PROCEDURAL SAFEGUARDS NOTICE PARENTAL RIGHTS FOR PRIVATE SCHOOL SPECIAL EDUCATION STUDENTS

I am having a Rotator Cuff Repair

Advance Care Planning Collaboration 101

Interpretation. Historical enquiry religious diversity

Getting Started. Learning Guide. with Continuous Glucose Monitoring for the MiniMed 530G with Enlite. CGM Foundations

All meetings and events held by, or on behalf of ESN Agder All ESN-related online activity All external representation of ESN and ESN Agder

Advantage EAP Employee Assistance Program

NEW PATIENT QUESTIONNAIRE-ADULT

Ontario Dress Purple Day: Lesson 3

Bariatric Surgery FAQs for Employees in the GRMC Group Health Plan

Susan Wortman, Career Development Center

454-8 (Insert) MEDICATION GUIDE ZUBSOLV (Zub-solve) (buprenorphine and naloxone) Sublingual Tablet (CIII) IMPORTANT: Keep ZUBSOLV in a secure place

Brief Addiction Monitor (BAM) With Scoring & Clinical Guidelines

The Interface Between Theory of Mind and Language Impairment

2. What is SO 2? 3. The World Health Organization states that air pollution.

Lee County Florida Income Guideline Chart

PSYCHOSEXUAL ASSESSMENTS for Children and Adolescents with Problematic Sexual Behavior. Who is qualified to conduct a psychosexual evaluation?

If you have any doubts or queries about your medication, please contact your doctor or pharmacist.

Signature Assignment. Course. ANTH 2346: General Anthropology. Assignment ID (to be assigned) Outcomes/Rubrics to be Assessed by the Assignment

PILI Lifestyle Program Facilitator s Guide

FTD RESEARCH: The Value of Studies and Opportunities for Involvement

Memory Screening Site s PROGRAM HANDBOOK

You may have a higher risk of bleeding if you take warfarin sodium tablets and:

GUIDANCE DOCUMENT FOR ENROLLING SUBJECTS WHO DO NOT SPEAK ENGLISH

Access to Heme Treatment in Canada - Survey 2018

Welcome! You will also learn about Deaf culture and Deaf history. What will we study?

PHARYNGO-OESOPHAGECTOMY

Influenza (Flu) Fact Sheet

Name of procedure: Removal of submandibular salivary gland

Head and neck cancers are often treated with radiotherapy. Radiotherapy can lead to faster rates of tooth decay and poor healing in the mouth.

Understanding and Recognizing Anxiety

Who is eligible for LifeCare? What services are available?

My Symptoms and Medical History for Adult Chronic Immune Thrombocytopenia (ITP)

Sunny Smiles Pediatric Dentistry

EVALUATION OF POVERTY AND STIGMA SESSIONS

Vaccine Information Statement: LIVE INTRANASAL INFLUENZA VACCINE

Percutaneous Nephrolithotomy (PCNL)

MEDICATION GUIDE. (fingolimod) capsules

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red.

CRANIOFACIAL RESECTION

PET FORM Planning and Evaluation Tracking ( Assessment Period)

Recommendations for Risk Management at Swine Exhibitions and for Show Pigs August 2012

Record of Revisions to Patient Tracking Spreadsheet Template

MEDICATION GUIDE Pioglitazone and Metformin Hydrochloride (PYE o GLI ta zone and met FOR min HYE-droe- KLOR-ide)Tablets, USP

2012 Indiana Parent/Family Needs Assessment Survey

Bedfordshire and Hertfordshire DRAFT Priorities forum statement Number: Subject: Prostatism Date of decision: January 2010 Date of review:

17831 Murdock Circle Port Charlotte, FL Information: or

MEDICATION GUIDE. (canagliflozin) Tablets

A pre-conference should include the following: an introduction, a discussion based on the review of lesson materials, and a summary of next steps.

Newborn Hearing Screening, Early Identification and Loss to Follow-Up

**Parent/Guardian Information for Minor Children. Information for Military Members. Referral Information

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red.

Medication Guide MORPHINE SULFATE (mor-pheen) Oral Solution (CII)

Anterior Total Hip Arthroplasty Patient Guide & Common Questions

GSB of EDA Meeting Minutes

PART III: CONSUMER INFORMATION

Food Stamp Program Pandemic Flu Planning

What is Asthma? A collaborative effort of Children s Hospital of Pittsburgh of UPMC and The Pennsylvania Child Welfare Resource Center

2019 Canada Winter Games Team NT Female Hockey Selection Camp August 16-19, 2018

Making Medicare + Medi-Cal Work for California s Dual Eligibles

Thank you for your interest in Pratt Community. College s Electrical Power Technology Program at. Coffeyville. Enclosed you will find a packet which

Idaho Naturopathic Medicine 6550 W Emerald, Ste 112 Boise, Idaho Ph: Fax:

INSTRUCTIONS FOR USE ZINBRYTA (zin-bry-tuh) (daclizumab) Injection, for Subcutaneous Use Single-Dose Prefilled Syringe 150 mg

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION

The Dizziness Handicap Inventory ( DHI )

French III/IV Syllabus Thomas County Central High School Ashley Olson-Room E

Transcription:

Appendix h STUDY NUMBER: COST OF UNSAFE ABORTION FOLLOW-UP IN-DEPTH INTERVIEW GUIDELINES T be administered abut 2-3 weeks after leaving the health facility 1. IDENTIFICATION 101. Patient identificatin number (WRITE IN FROM Q101 IN WOMEN S QUESTIONNAIRE): 102. Date when patient was discharged frm health facility: / / / (WRITE IN FROM Q211 IN PROVIDER S QNNAIRE) Day Mnth Year 998 = Permissin nt given 103. Date f fllw-up IDI: / / / Day Mnth Year 104. Days r weeks patient waited befre arriving at health facility: (WRITE IN FROM Q601 IN WOMEN S QUESTIONNAIRE) days OR weeks 105. Interviewer's name 106. Language f fllw-up interview 107. Number f cntacts made fr fllw-up interview 1 st cntact attempt / / / Day Mnth Year 2 nd cntact attempt / / / Day Mnth Year 3 rd cntact attempt / / / Day Mnth Year 108. Final result f fllw-up IDI: 1. Cmpleted 2. Partly Cmpleted (explain) 3. Refused 4. Respndent incapacitated 5. Respndent nt at hme r did nt shw fr appintment 6. Respndent pstpned 7. Respndent died 8. Other (specify) 109. Time fllw-up interview: Started: Ended: Guttmacher Institute - Assessing the public health, 1scial and ecnmic csts f unsafe abrtin (#RHB5R121)

STUDY NUMBER: 2. INTRODUCTION AND CONSENT Hell Madam. My name is and I am wrking with the [NAME OF ORGANIZATION]. As yu may recall, sme weeks ag we had the pprtunity t talk at [NAME OF HEALTH FACILITY] when yu were receiving medical treatment. At that time yu kindly agreed t meet again t cntinue that cnversatin. I wuld like t request yur cllabratin again in this study by answering sme questins abut hw yur health has been since yu left [NAME OF FACILITY], the expenses yu may have had and in general hw was yur experience there. If yu agree, yu will be interviewed fr abut ne hur Yur participatin is entirely vluntary and yu will nt receive a direct benefit fr participating. We want t audi tape recrd the interview s that we are able t g back and review the respnses later thus, nt missing any details. Participatin in this study is nly pssible if yu are willing t have the discussin recrded. If yu decide t take part, yu may stp at any time if yu d nt want t cntinue, and yu may refuse t answer any questin if it makes yu uncmfrtable. N infrmatin which culd identify yu will ever be released. D yu have any questins abut this study tday that yu want t ask me? If yu have any questins later abut the study, yu can cntact [PRINCIPAL INVESTIGATOR] f [NAME OF ORGANIZATION] at [TELEPHONE NUMBER]. 2

If yu agree t be interviewed and t have the interview audi tape recrded, please sign r write yur initials in the space belw prvided fr bth agreements t shw that yu understand the infrmatin abve and that yur cnsent is given vluntarily. I agree t be interviewed and t have the interview audi tape recrded (Respndent) (Date) IF PERSON IS UNWILLING TO INITIAL OR SIGN OR UNABLE TO READ OR SIGN BUT AGREES TO BE A PARTICIPANT: I [the interviewer] will sign here indicating that the infrmatin abve was read t yu, that yu agree t participate in this interview and that yur cnsent is given vluntarily. (Interviewer) (Date) 3

3. INTERVIEW GUIDELINES INTERVIEWER: PLEASE REMIND THE RESPONDENT AT ALL TIMES, IN ALL QUESTIONS THAT WE ARE REFERRING TO THE TIME SINCE SHE WAS DISCHARGED FROM THE HEALTH FACILITY FOR POST-ABORTION TREATMENT (QUESTION 102) AND TODAY S DATE (QUESTION 103). A. Please tell me abut hw yur health has been since yu left (NAME OF HEALTH FACILITY)? What kind f health prblems have yu experienced, if any? IF NO HEALTH PROBLEMS, GO TO B. Hw have these health prblems prevented yu frm ding yur nrmal activities (schl, wrk, husehld chres), if at all? What specific activities were yu unable t perfrm? Hw lng were yu unable t perfrm these activities? Did yu lse any incme during this time? If s, hw much incme did yu lse? [PROBE FOR ESTIMATE] Did anyne else in yur husehld lse incme during this time because f yur illness? If s, hw much incme did he/she lse? [PROBE FOR ESTIMATE] Did yur health prblems cause yu t seek treatment? B. Let us talk in mre detail abut the expenses yu, a family member r smene else may have incurred since yu left the health facility (date in 102). [IF RESPONDENT SAYS SHE WENT TO HEALTH FACILITY ONE OR MORE TIMES AFTER BEING DISCHARGED, SAY YOU ARE ASKING ABOUT EXPENSES FOR ALL VISITS. PROBE FOR ESTIMATE] Did yu r smene else pay fr transprtatin when yu left the health facility? If s, abut hw much was it? Did yu r smene else pay fees fr health facility visits since then? If s, abut hw much (fr all visits since discharge)? Did yu r smene else pay fr any fr tests since then? If s, abut hw much (fr all tests since discharge)? Did yu r smene else pay fr medicines r supplies prescribed after being discharged? If s, abut hw much? 4

Were there any ther csts yu r smene else had t cver? What were thse csts? Abut hw much were these additinal csts in ttal? C. Nw let s talk abut yur life and feelings after returning frm the health facility. In what ways have yur usual scial activities changed r nt? What were the reasns why yur usual scial activities have (r have nt) changed? Are there any things yu wanted t d but have nt been able t? What things have yu been unable t d? Any reasn(s) that made yu nt been able t d them? As far as yu knw, did anyne find ut that yu had an abrtin r that yu were in the hspital because yu needed pst-abrtin care? (If yes) Wh fund ut? What was (his/her/their) reactin? Culd yu describe it (give an example)? Hw did yu feel because f his/her/their reactin? Did it bther yu r make yu feel relieved? Has anyne been supprtive? If s, wh has been supprtive and in what ways? In yur pinin, hw were peple s attitudes r behavirs tward yu because f yur abrtin? Any change in (his/her/their) behavirs that yu bserved? Culd yu give me an example hw his/her attitude r behavir changed? Hw des this attitude r behavir change make yu feel? When yu started having health prblems as a result f the abrtin, yu waited sme time (SEE QUESTION 104) befre ging t the health facility. Culd yu tell me what that prevented yu frm ging sner? Were yu afraid f smene r smething? Culd yu tell me wh r what yu were afraid f and why yu felt afraid? Culd yu tell me hw yur experience at the health facility was when yu were treated fr the abrtin cmplicatins f yur last pregnancy? Hw many hurs did yu wait befre receiving treatment? Hw did the staff treat yu? THANK YOU VERY MUCH FOR YOUR TIME INTERVIEWER: RECORD ENDING TIME IN Q109 ON FIRST PAGE. 5